Madhumati is a Senior Scientist in the Bioassay, Biosafety, and Impurities group at AstraZeneca where she specializes in developing potency assays for lot-release, stability and characterization of various biologics including ADCs and inhaled biologics. Before joining AZ, Madhumati held a similar role in Bristol-Myers Squibb, where she not only focused on potency assay development but also served as an analytical lead responsible for the CMC-Analytical control strategy. Madhumati earned her Ph.D in Genetics from University of Georgia and holds an M.S. in Biology from West Virginia University.